Breaks Categories: News

TuesdaySep 26, 2017 9:26 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Enters Letter of Intent to Acquire Stake in Denver-Based Company

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced that it has signed a Letter of Intent (“LOI”) to acquire a Denver, Colorado-based company that is approaching $1 million in annual revenue. Per the LOI, SinglePoint will acquire 51 percent of the acquisition target in a stock and cash transaction that’s expected to increase shareholder and company value by delivering immediate revenues with a healthy margin. “We are committed to identifying and making investments in companies that strengthen SinglePoint's value,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “Our goal is to find and acquire companies we…

Continue Reading

MondaySep 25, 2017 11:46 am

NetworkNewsBreaks – Aradigm Corp.’s (NASDAQ: ARDM) NDA for Linhaliq Accepted For Filing With Priority Review Status By FDA; Shares Surge

Shares of Aradigm (NASDAQ: ARDM) are up 26% after the company this morning said its New Drug Application (NDA) for Linhaliq™ for the treatment of non-cystic fibrosis bronchiectasis (NCFBE) patients with chronic infections with Pseudomonas aeruginosa (P. aeruginosa) has been accepted for filing with Priority Review by the U.S. Food and Drug Administration (FDA). Priority Review advances the FDA review of the application more quickly than a standard review. The company’s PDUFA (Prescription Drug User Fee Act) goal date for completion of the FDA review is January 26, 2018. “We look forward to working with the FDA during the review…

Continue Reading

MondaySep 25, 2017 11:35 am

NetworkNewsBreaks – Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) Launches New Molecular Lung Cancer Test

Interpace Diagnostics Group (NASDAQ: IDXG) shares are up 6% after the company this morning announced the launch of its new lung cancer test, MVPdX™. The test distinguishes the local recurrence of cancer versus new primary cancer formation. The company’s Medicare Administrative Carrier and many commercial carriers already cover the MVPdX test. “This represents a significant milestone for the company as we expand our menu to include an entirely new vertical line of business in lung assays using our already proven technology. We believe this initiative will further diversify our product offering while potentially providing for further expansion of our revenues,”…

Continue Reading

MondaySep 25, 2017 9:32 am

NetworkNewsBreaks – The Green Organic Dutchman (“TGOD”) Introduces New CFO and VP of Horticulture

The Green Organic Dutchman Holdings Ltd. (“TGOD”) recently announced the hiring of Amy Stephenson as its new chief financial officer and David Peron as its new vice president of horticulture. Stephenson has over 20 years of executive experience in both the private and public sectors which includes working with market leaders in the Canadian cannabis industry. Peron is an agrologist and holds a master of science degree in plant sciences from McGill University. He is also chief science officer for Destiny Biotechnology, which provides living soil systems for organic cannabis production. “This is another step forward for The Green Organic…

Continue Reading

MondaySep 25, 2017 9:06 am

NetworkNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Provides Update on Advancements of Proprietary Biosynthesis Technology

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning provided an update to its investors on the significant advancements in the development of its proprietary technology for the microbial biosynthesis of cannabinoids. InMed has successfully demonstrated that it can selectively produce all four “gateway” cannabinoids using genetically engineered microorganisms. These molecules can be further functionalized to produce any of the 90+ cannabinoids that occur naturally in the cannabis plant. “Successful scale-up and commercialization of the biosynthesis process for cannabinoid production is a top priority for InMed,” Eric A. Adams, president and CEO of InMed, stated in…

Continue Reading

FridaySep 22, 2017 9:22 am

NetworkNewsBreaks – Alltemp (LTMP) Partners with Trinity to Offer Comprehensive Extended Warranty Coverage

Alltemp, Inc. (OTCQB: LTMP), a developer of proprietary, environmentally friendly refrigerant technologies, is now able to offer a strong third-party extended warranty for clients whose HVAC systems are running alltemp refrigerants backed by Trinity Warranty. The extended warranty plan is available to most alltemp users and can enhance the manufacturer’s warranty, with an option for up to a 10-year extension that can include parts and labor. “We believe that we designed alltemp to be the best refrigerant on the market and we are now backing it up with the best extended service agreements available,” William Lopshire, Alltemp CEO, said in…

Continue Reading

FridaySep 22, 2017 9:20 am

NetworkNewsBreaks – American Cannabis Company, Inc. (AMMJ) Signs Exclusive Distribution Agreement with Earth Alive

American Cannabis Company, Inc. (OTCQB: AMMJ), a full-service, business-to-business consulting solutions provider and seller of ancillary products to the cannabis industry, has signed an exclusive distribution agreement with Earth Alive, a leading Canadian clean-tech company that develops and manufactures state-of-the-art microbial technology-based products. This agreement allows Earth Alive’s premiere cannabis microbial inoculant product, “Dr. Marijane,” a certified organic root probiotic proven to increase cannabis yields by up to 28%, to be commercialized. “We are very happy to be given the opportunity to exclusively distribute Dr. Marijane,” Terry Buffalo, CEO of American Cannabis Company, Inc., said in a news release. “Dr.…

Continue Reading

ThursdaySep 21, 2017 1:59 pm

NetworkNewsBreaks – GB Sciences, Inc. (GBLX) Forges Innovative Partnership with LSU AgCenter to Advance Understanding of Cannabis

GB Sciences, Inc. (OTCQB: GBLX) and Louisiana State University ("LSU") AgCenter recently announced an agreement with GB Sciences Louisiana, LLC, a wholly owned subsidiary of GB Sciences, Inc., to produce medical cannabis products for qualifying patients. The agreement, conducted under compliance with the Alison Neustrom Act, will allow GB Sciences to produce medical cannabis under the AgCenter’s license. In a news release, GB Sciences, Inc. stated that the agreement is “historic” and creates a formidable partnership. GB Sciences is a publicly traded cannabis company firmly rooted in science. This partnership with LSU, a major research university, is dedicated to advancing…

Continue Reading

ThursdaySep 21, 2017 11:52 am

NetworkNewsBreaks – Tantech Holdings Ltd.’s (NASDAQ: TANH) Subsidiary Secures $20M Electric Vehicle Order

Tantech Holdings (NASDAQ: TANH) this morning said that its 70% owned subsidiary, Suzhou E Motors Buses Co., Ltd., has signed sales contracts for its electric vans and buses worth approximately $20 million. Per the contracts, Zhenjiang Baichuan New Energy Automobile Co., Ltd. intends to purchase 450 all-electric vans and 10 all-electric buses from Tantech with a projected unit sales price of U.S. $43,077. In addition to the unit sales price, Tantech may be eligible to receive Chinese government subsidies for electric car sales. Tantech is expecting to deliver the order by the end of 2017. "In addition to manufacturing a…

Continue Reading

ThursdaySep 21, 2017 11:50 am

NetworkNewsBreaks – Onconova Therapeutics, Inc. (NASDAQ: ONTX) Enters Strategic Collaboration with Cellectar Biosciences, Inc. (NASDAQ: CLRB) to Develop New PDCs

Shares of Onconova Therapeutics (NASDAQ: ONTX) are up 6% after the company this morning said it has entered into a strategic collaboration with Cellectar Biosciences (NASDAQ: CLRB) to develop new phospholipid drug conjugates (PDCs). The companies intend to combine Cellectar’s patented phospholipid ether delivery platform with select proprietary compounds or payloads from Onconova’s early stage product pipeline. Per the terms of the collaboration, Onconova will provide several compounds to Cellectar, which will then link to its PDC platform to create new, more precisely targeted antitumor agents. “We are focused on optimizing the delivery of our therapeutic compounds in the battle…

Continue Reading